Showing 1–50 of 62 results

2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $2,601.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $4,161.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $2,601.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$718.00 – $4,161.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $7,700.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $4,161.00
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$704.00 – $7,700.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $4,161.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$718.00 – $4,161.00
+
 Quick View

anti-human

Blinatumomab Biosimilar – Research Grade [ICH5025]

$718.00 – $4,161.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$300.00 – $4,161.00
2020 FDA Approvals for Panitumumab
+
 Quick View

anti-human

Panitumumab Biosimilar – Research Grade [ICH4028]

$718.00 – $4,161.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $4,161.00
+
 Quick View

anti-human

Urelumab Biosimilar – Research Grade [ICH5015]

$718.00 – $4,161.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $4,161.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $4,161.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$300.00 – $4,161.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $4,161.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $4,161.00
+
 Quick View

anti-human

Theralizumab Biosimilar – Research Grade [ICH5023]

$718.00 – $4,161.00
+
 Quick View

anti-human

Utomilumab Biosimilar – Research Grade [ICH5014]

$718.00 – $4,161.00
2020 FDA Approvals for Vedolizumab
+
 Quick View

anti-human

Vedolizumab Biosimilar – Research Grade [ICH4035]

$718.00 – $4,161.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $4,161.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $4,161.00
2020 FDA Approvals for Tocilizumab
+
 Quick View

anti-human

Tocilizumab Biosimilar – Research Grade [ICH4012]

$936.00 – $2,601.00
2020 FDA Approvals for Rituximab
+
 Quick View

anti-human

Rituximab Biosimilar – Research Grade [ICH4011]

$718.00 – $4,161.00
2020 FDA Approvals for Nivolumab
+
 Quick View

anti-human

Nivolumab Biosimilar – Research Grade [ICH4009]

$718.00 – $4,161.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$718.00 – $4,161.00
Western Blot of Infliximab Biosimilar ICH40062020 FDA Approvals Infliximab
+
 Quick View

anti-human

Infliximab Biosimilar – Research Grade [ICH4006]

$718.00 – $4,161.00
+
 Quick View

Antibodies

Rovalpituzumab Biosimilar – Research Grade [ICH5048]

$718.00 – $4,161.00
+
 Quick View

Antibodies

Belimumab Biosimilar – Research Grade [ICH5080]

$718.00 – $4,161.00
+
 Quick View

anti-human

Mosunetuzumab Biosimilar – Research Grade [ICH5026]

$718.00 – $4,161.00
+
 Quick View

anti-human

Muromonab-CD3 Biosimilar – Research Grade [ICH5024]

$718.00 – $4,161.00
+
 Quick View

anti-human

Varlilumab Biosimilar – Research Grade [ICH5022]

$718.00 – $4,161.00
+
 Quick View

anti-human

Daclizumab Biosimilar – Research Grade [ICH5021]

$718.00 – $4,161.00
+
 Quick View

anti-human

Moxetumomab pasudotox Biosimilar – Research Grade [ICH5020]

$718.00 – $4,161.00
+
 Quick View

anti-human

Glofitamab Biosimilar – Research Grade [ICH5019]

$718.00 – $4,161.00
+
 Quick View

anti-human

MDX-1342 Biosimilar – Research Grade [ICH5018]

$718.00 – $4,161.00
+
 Quick View

anti-human

Monalizumab Biosimilar – Research Grade [ICH5017]

$718.00 – $4,161.00
+
 Quick View

anti-human

Atibuclimab Biosimilar – Research Grade [ICH5016]

$718.00 – $4,161.00
+
 Quick View

anti-human

Girentuximab Biosimilar – Research Grade [ICH5013]

$718.00 – $4,161.00
+
 Quick View

anti-human

Sutimlimab Biosimilar – Research Grade [ICH5012]

$718.00 – $4,161.00
+
 Quick View

anti-human

Belantamab mafodotin Biosimilar – Research Grade [ICH5011]

$718.00 – $4,161.00
+
 Quick View

anti-human

Nesvacumab Biosimilar – Research Grade [ICH5010]

$718.00 – $4,161.00
+
 Quick View

anti-human

Gantenerumab Biosimilar – Research Grade [ICH5009]

$718.00 – $4,161.00
+
 Quick View

anti-human

Aducanumab Biosimilar – Research Grade [ICH5008]

$718.00 – $4,161.00
+
 Quick View

anti-human

Naptumomab Biosimilar – Research Grade [ICH5007]

$718.00 – $4,161.00
+
 Quick View

anti-human

M7824 Biosimilar – Research Grade [ICH5006]

$718.00 – $4,161.00
Western Blot of Durvalumab Biosimilar ICH5005
+
 Quick View

anti-human

Durvalumab Biosimilar – Research Grade [ICH5005]

$718.00 – $4,161.00
Western Blot of Tislelizumab Biosimilar ICH5004
+
 Quick View

anti-human

Tislelizumab Biosimilar – Research Grade [ICH5004]

$718.00 – $4,161.00